Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Class A common stock, par value $0.0001 per share
-
Shares outstanding
-
1.26M
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
689K
-
Shares change
-
-55.2K
-
Total reported value, excl. options
-
$8.16M
-
Value change
-
-$639K
-
Number of buys
-
3
-
Number of sells
-
-5
-
Price
-
$11.86
Significant Holders of Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) as of Q4 2024
8 filings reported holding DNQAF - Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share as of Q4 2024.
Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 689K shares
of 1.26M outstanding shares and own 54.65% of the company stock.
Largest 8 shareholders include METEORA CAPITAL, LLC (512K shares), TORONTO DOMINION BANK (80K shares), ATW SPAC MANAGEMENT LLC (37.5K shares), BOOTHBAY FUND MANAGEMENT, LLC (37.5K shares), CLEAR STREET LLC (20K shares), UBS Group AG (2.25K shares), COWEN AND COMPANY, LLC (0 shares), and Virtu Financial LLC (0 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.